Paxlovid for B.C. residents

Last updated on July 30, 2024

Prescribers and pharmacists, visit Paxlovid information for health professionals

A non-profit research study is seeking B.C. participants. For more information, visit https://cantreatcovid.org

Nirmatrelvir/ritonavir (Paxlovid™) is a COVID-19 treatment prescribed to reduce the risk of hospitalization for adults who are moderate-to-severely immunocompromised, and/or 60 years or older with a high-risk chronic condition.

B.C. residents must be enrolled in Medical Services Plan (MSP) to get PharmaCare coverage for Paxlovid.

Paxlovid is unnecessary for most people living in B.C. It is only beneficial for people who are considered at a higher risk for developing serious illness, such as people who are severely immunosuppressed.

Most B.C. residents won’t benefit from Paxlovid. People are asked to reserve resources for those who really need Paxlovid. Talk to your prescriber about Paxlovid, including the safety risks associated with it. Paxlovid is known to interact with many medications and is linked to side effects.

Most B.C. residents have developed a strong immunity to COVID-19 through previous infections and vaccinations. Most people can safely manage their COVID-19 symptoms at home through self-care

Graphic with wording that says: For most people in B.C., Paxlovid won't make you feel better faster, and won't lower your chance of going to hospital or dying

Questions?

Resources

Did you find what you were looking for?

The B.C. Public Service acknowledges the territories of First Nations around B.C. and is grateful to carry out our work on these lands. We acknowledge the rights, interests, priorities, and concerns of all Indigenous Peoples - First Nations, Métis, and Inuit - respecting and acknowledging their distinct cultures, histories, rights, laws, and governments.

More topics

Paxlovid for B.C. residents

Questions?

Resources